|
||
IIb
3 by
3-Endonexin, a Selective
Binding Partner of the
3 Integrin Cytoplasmic Tail

* Department of Vascular Biology, Platelet agonists increase the affinity state of
integrin
Department of Molecular and Experimental Medicine, The Scripps Research Institute, La
Jolla, California 92037; and § Becton-Dickinson Immunocytometry Systems, San Jose, California 95131
IIb
3, a prerequisite for fibrinogen binding
and platelet aggregation. This process may be triggered
by a regulatory molecule(s) that binds to the integrin
cytoplasmic tails, causing a structural change in the receptor.
3-Endonexin is a novel 111-amino acid protein
that binds selectively to the
3 tail. Since
3-endonexin is present in platelets, we asked whether it can affect
IIb
3 function. When
3-endonexin was fused to green
fluorescent protein (GFP) and transfected into CHO
cells, it was found in both the cytoplasm and the nucleus and could be detected on Western blots of cell lysates. PAC1, a fibrinogen-mimetic mAb, was used to
monitor
IIb
3 affinity state in transfected cells by flow
cytometry. Cells transfected with GFP and
IIb
3 bound
little or no PAC1. However, those transfected with
GFP/
3-endonexin and
IIb
3 bound PAC1 specifically
in an energy-dependent fashion, and they underwent fibrinogen-dependent aggregation. GFP/
3-endonexin
did not affect levels of surface expression of
IIb
3 nor
did it modulate the affinity of an
IIb
3 mutant that is
defective in binding to
3-endonexin. Affinity modulation of
IIb
3 by GFP/
3-endonexin was inhibited by coexpression of either a monomeric
3 cytoplasmic tail
chimera or an activated form of H-Ras. These results
demonstrate that
3-endonexin can modulate the affinity state of
IIb
3 in a manner that is structurally specific
and subject to metabolic regulation. By analogy, the adhesive function of platelets may be regulated by such
protein-protein interactions at the level of the cytoplasmic tails of
IIb
3.
This article has been cited by other articles:
|
|